CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $54,481,000 | +1.5% | 64,864,000 | +86.9% | 1.45% | +37.3% |
| Q3 2017 | $53,670,000 | -32.4% | 34,710,000 | -25.8% | 1.06% | -50.7% |
| Q2 2017 | $79,428,000 | -14.8% | 46,790,999 | -35.1% | 2.14% | -8.4% |
| Q1 2017 | $93,238,000 | +17.9% | 72,138,000 | -5.8% | 2.34% | +4.8% |
| Q4 2016 | $79,100,000 | +0.7% | 76,610,000 | -7.3% | 2.23% | -3.0% |
| Q3 2016 | $78,516,000 | +16.4% | 82,648,000 | -12.8% | 2.30% | +12.9% |
| Q2 2016 | $67,474,000 | +1980.6% | 94,784,000 | +1896.7% | 2.04% | +1936.0% |
| Q1 2016 | $3,243,000 | -18.7% | 4,747,000 | +2.4% | 0.10% | -17.4% |
| Q4 2015 | $3,988,000 | -50.4% | 4,637,000 | -3.5% | 0.12% | -46.5% |
| Q3 2015 | $8,045,000 | – | 4,805,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 70,125,000 | $118,981,000 | 5.01% |
| PFM Health Sciences, LP | 46,790,999 | $79,428,000 | 2.14% |
| Partner Investment Management, L.P. | 790,001 | $1,341,000 | 1.80% |
| Myriad Asset Management Ltd. | 10,000,000 | $16,984,000 | 1.18% |
| CSS LLC/IL | 10,950,000 | $18,558,000 | 0.90% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 9,074,000 | $15,403,000 | 0.42% |
| SSI INVESTMENT MANAGEMENT LLC | 2,784,000 | $4,715,000 | 0.42% |
| ZAZOVE ASSOCIATES LLC | 4,030,000 | $6,833,000 | 0.36% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,826,000 | $13,277,000 | 0.25% |
| LORD, ABBETT & CO. LLC | 18,243,000 | $30,967,000 | 0.09% |